St Germain D J CO Inc Alnylam Pharmaceuticals, Inc. Transaction History
St Germain D J CO Inc
- $2.22 Billion
- Q2 2025
A detailed history of St Germain D J CO Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, St Germain D J CO Inc holds 8,994 shares of ALNY stock, worth $2.92 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
8,994Holding current value
$2.92 Million% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
724Shares Held
111MCall Options Held
966KPut Options Held
853K-
Capital World Investors Los Angeles, CA16.7MShares$5.44 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$4.24 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$3.1 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$2.32 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.42MShares$1.43 Billion0.79% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $40B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...